amylin vs glp-1 The current range of weight-loss drugs on the market targets receptors. Seeking a new generation of weight-loss drugs, some companies are developing analogs. Read more at the link in our 📢 Beyond GLP-1: The next

Low brand awareness notwithstanding, Auro Wellness has managed to build a $4 millionplus business in four years via distribution in the offices of licensed health care providers from MDs to dentists, as well as independent pharmacists

Our experts are sharing six major market shifts that are reshaping obesity treatment, and their thoughts on how pharma leaders and providers should respond

Perfect for those seeking effective immune support with clean, natural ingredients.*

May your protein stay high, your meals stay satisfying, and your results stay consistent.

Consult your doctor if you experience unusual weakness, frequent urination, or any diabetes-associated side effects after taking this medicine

Eli Lilly is slashing introductory prices for its blockbuster weightloss drug Zepbound yet againsignaling intensifying competition with Novo Nordisks Wegovy and Ozempic